Vitrolife AB (VITR) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.020x

Based on the latest financial reports, Vitrolife AB (VITR) has a cash flow conversion efficiency ratio of 0.020x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr160.00 Million ≈ $17.22 Million USD) by net assets (Skr7.89 Billion ≈ $849.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Vitrolife AB - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Vitrolife AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Vitrolife AB for a breakdown of total debt and financial obligations.

Vitrolife AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vitrolife AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shanxi Lanhua Sci-Tech Venture Co Ltd
SHG:600123
0.014x
EZCORP Inc
NASDAQ:EZPW
0.037x
Zoomlion Heavy Industry Science and Technology Co. Ltd
F:8CZ
0.019x
Five-Star Business Finance Limited
NSE:FIVESTAR
0.002x
Beijing VRV Software Corp Ltd
SHE:300352
0.012x
FLEX LNG Ltd
NYSE:FLNG
0.040x
CBIZ Inc
NYSE:CBZ
0.013x
NRW Holdings Limited
F:3NR
0.169x

Annual Cash Flow Conversion Efficiency for Vitrolife AB (2002–2025)

The table below shows the annual cash flow conversion efficiency of Vitrolife AB from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Vitrolife AB (VITR) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr7.89 Billion
≈ $849.63 Million
Skr635.00 Million
≈ $68.34 Million
0.080x +20.97%
2024-12-31 Skr13.64 Billion
≈ $1.47 Billion
Skr907.00 Million
≈ $97.61 Million
0.066x +11.75%
2023-12-31 Skr12.72 Billion
≈ $1.37 Billion
Skr757.00 Million
≈ $81.47 Million
0.059x +56.60%
2022-12-31 Skr16.74 Billion
≈ $1.80 Billion
Skr636.00 Million
≈ $68.44 Million
0.038x +51.66%
2021-12-31 Skr15.34 Billion
≈ $1.65 Billion
Skr384.31 Million
≈ $41.36 Million
0.025x -85.82%
2020-12-31 Skr2.02 Billion
≈ $217.06 Million
Skr356.45 Million
≈ $38.36 Million
0.177x -23.14%
2019-12-31 Skr1.80 Billion
≈ $193.45 Million
Skr413.33 Million
≈ $44.48 Million
0.230x -1.55%
2018-12-31 Skr1.50 Billion
≈ $161.02 Million
Skr349.44 Million
≈ $37.60 Million
0.234x -8.09%
2017-12-31 Skr1.23 Billion
≈ $132.22 Million
Skr312.19 Million
≈ $33.60 Million
0.254x +43.04%
2016-12-31 Skr1.02 Billion
≈ $109.81 Million
Skr181.26 Million
≈ $19.51 Million
0.178x -22.44%
2015-12-31 Skr844.97 Million
≈ $90.93 Million
Skr193.53 Million
≈ $20.83 Million
0.229x +10.47%
2014-12-31 Skr702.57 Million
≈ $75.61 Million
Skr145.67 Million
≈ $15.68 Million
0.207x -36.98%
2013-12-31 Skr322.60 Million
≈ $34.72 Million
Skr106.13 Million
≈ $11.42 Million
0.329x +53.14%
2012-12-31 Skr278.98 Million
≈ $30.02 Million
Skr59.93 Million
≈ $6.45 Million
0.215x +87.22%
2011-12-31 Skr343.90 Million
≈ $37.01 Million
Skr39.46 Million
≈ $4.25 Million
0.115x -22.63%
2010-12-31 Skr326.33 Million
≈ $35.12 Million
Skr48.40 Million
≈ $5.21 Million
0.148x +11.59%
2009-12-31 Skr312.07 Million
≈ $33.58 Million
Skr41.48 Million
≈ $4.46 Million
0.133x -9.19%
2008-12-31 Skr292.39 Million
≈ $31.47 Million
Skr42.79 Million
≈ $4.61 Million
0.146x +74.23%
2007-12-31 Skr253.38 Million
≈ $27.27 Million
Skr21.29 Million
≈ $2.29 Million
0.084x -22.07%
2006-12-31 Skr220.64 Million
≈ $23.74 Million
Skr23.78 Million
≈ $2.56 Million
0.108x +34.70%
2005-12-31 Skr176.45 Million
≈ $18.99 Million
Skr14.12 Million
≈ $1.52 Million
0.080x -13.96%
2004-12-31 Skr150.57 Million
≈ $16.20 Million
Skr14.01 Million
≈ $1.51 Million
0.093x -57.25%
2003-12-31 Skr143.44 Million
≈ $15.44 Million
Skr31.20 Million
≈ $3.36 Million
0.218x -30.30%
2002-12-31 Skr111.40 Million
≈ $11.99 Million
Skr34.77 Million
≈ $3.74 Million
0.312x --

About Vitrolife AB

ST:VITR Sweden Medical Devices
Market Cap
$1.53 Billion
Skr14.18 Billion SEK
Market Cap Rank
#7317 Global
#104 in Sweden
Share Price
Skr104.70
Change (1 day)
+0.38%
52-Week Range
Skr85.70 - Skr161.50
All Time High
Skr560.50
About

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware … Read more